The story of Viagra offers a intricate case study for investors eyeing the pharmaceutical sector. While first sales were remarkable, current patent lapse and the emergence of generic versions have significantly https://siobhaniwst299045.blogdemls.com/40824128/the-blue-pill-and-pharma-a-precarious-stake